v3 Template
A

Autoimmunity BioSolutions

Biotechnology / Healthcare Houston, Texas, USA ~380 employees
Founded
--
Employees (Est.)
~380
19 leaders known
Total Funding
$2.0M
Funding Rounds
1
Last Funding
2024-11-21

About Autoimmunity BioSolutions

Autoimmunity BioSolutions (ABS) is a biotechnology company focused on developing next-generation, immuno-corrective therapies for autoimmune disease treatment. Their mission is to create precision therapies and biomarkers targeting genetically-defined subpopulations, specifically those with elevated soluble IL7 receptor (sIL7R), to restore normal immune function and improve treatment outcomes for patients resistant to standard care.

Products & Services

Immuno-Corrective Therapy:A novel therapy targeting soluble IL7 receptor (sIL7R) to normalize immune function in autoimmune disease patients with specific genetic profiles.
Precision Therapies (mAbs and ASOs):Monoclonal antibodies (mAbs) and antisense oligonucleotides (ASOs) designed to reduce sIL7R levels in genetically at-risk populations.
Biomarkers:Tools to identify responder populations for current or emerging standards of care in autoimmune disease treatment.

Specialties

Immuno-Corrective Therapy Autoimmune Disease Treatment Precision Medicine Soluble IL7 Receptor (sIL7R) Targeting Genetic-Based Therapies Biomarker Development

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series Seed
T: -
FT: Series Seed
A: 2000000
MR: -
FA: $2M
FAN: 2000000
D: 2024-11-21
FD: 2024-11-21
3 investors
Series Seed Latest
2024-11-21
$2.0M
3 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

P

Patrick Hextall

mAb Drug Development & CMC

LinkedIn (Pro only)
M

Mark Maginn

NHP Pharmacology & GLP Toxicology

LinkedIn (Pro only)
T

Thomas Forest Farb-Horch

Co-founder & Business Advisor

LinkedIn (Pro only)
T

Takashi Kiyoizumi

Business Advisor

M

Mariano A. Garcia-Blanco

Co-founder and Board Director

G

George Hutton

SAB Member

View 16 more team members with Pro

Unlock Full Team Directory

Recent News

Autoimmunity BioSolutions Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~380 employees (est.)
Locations
Houston, Texas, USA

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro